|
1
|
Liu C, Zhang H, Tang X, Feng R, Yao G,
Chen W, Li W, Liang J, Feng X and Sun L: Mesenchymal stem cells
promote the osteo-genesis in collagen-induced arthritic mice
through the inhibition of TNF-α. Stem Cells Int. 2018:40690322018.
View Article : Google Scholar
|
|
2
|
Huang Z, Cheng C, Cao B, Wang J, Wei H,
Liu X, Han Y, Yang S and Wang X: Icariin protects against
glucocorticoid-induced osteonecrosis of the femoral head in rats.
Cell Physiol Biochem. 47:694–706. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wei Q, He M, Chen M, Chen Z, Yang F, Wang
H, Zhang J and He W: Icariin stimulates osteogenic differentiation
of rat bone marrow stromal stem cells by increasing TAZ expression.
Biomed Pharmacother. 91:581–589. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang D, Park BM, Kang M, Nam H, Kim EJ,
Bae C and Lim SK: The systemic effects of sclerostin overexpression
using ΦC31 integrase in mice. Biochem Biophys Res Commun.
472:471–476. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pietrzyk B, Smertka M and Chudek J:
Sclerostin: Intracellular mechanisms of action and its role in the
pathogenesis of skeletal and vascular disorders. Adv Clin Exp Med.
26:1283–1291. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
McDonald MM, Morse A, Birke O, Yu NYC,
Mikulec K, Peacock L, Schindeler A, Liu M, Ke HZ and Little DG:
Sclerostin antibody enhances bone formation in a rat model of
distraction osteogenesis. J Orthop Res. 36:1106–1113. 2018.
|
|
7
|
McClung MR: Sclerostin antibodies in
osteoporosis: Latest evidence and therapeutic potential. Ther Adv
Musculoskelet Dis. 9:263–270. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mirza FS, Padhi ID, Raisz LG and Lorenzo
JA: Serum sclerostin levels negatively correlate with parathyroid
hormone levels and free estrogen index in postmenopausal women. J
Clin Endocrinol Metab. 95:1991–1997. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim RY, Yang HJ, Song YM, Kim IS and Hwang
SJ: Estrogen modulates bone morphogenetic protein-induced
sclerostin expression through the Wnt signaling pathway. Tissue Eng
Part A. 21:2076–2088. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang JM, Bao Y, Xiang W, Jing XZ, Guo JC,
Yao XD, Wang R and Guo FJ: Icariin regulates the bidirectional
differentiation of bone marrow mesenchymal stem cells through
canonical Wnt signaling pathway. Evid Based Complement Alternat
Med. 2017:80853252017. View Article : Google Scholar
|
|
11
|
Wu T, Shu T, Kang L, Wu J, Xing J, Lu Z,
Chen S and Lv J: Icaritin, a novel plant-derived osteoinductive
agent, enhances the osteogenic differentiation of human bone
marrow- and human adipose tissue-derived mesenchymal stem cells.
Int J Mol Med. 39:984–992. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang ZQ and Lou YJ:
Proliferation-stimulating effects of icaritin and desmethylicaritin
in MCF-7 cells. Eur J Pharmacol. 504:147–153. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Baron R and Gori F: Targeting WNT
signaling in the treatment of osteoporosis. Curr Opin Pharmacol.
40:134–141. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sheng H, Rui XF, Sheng CJ, Li WJ, Cheng
XY, Jhummon NP, Yu YC, Qu S, Zhang G and Qin L: A novel
semisynthetic molecule icaritin stimulates osteogenic
differentiation and inhibits adipogenesis of mesenchymal stem
cells. Int J Med Sci. 10:782–789. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
16
|
Harrison G, Shapiro IM and Golub EE: The
phosphatidylinositol-glycolipid anchor on alkaline phosphatase
facilitates mineralization initiation in vitro. J Bone Miner Res.
10:568–573. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Orimo H: The mechanism of mineralization
and the role of alkaline phosphatase in health and disease. J
Nippon Med Sch. 77:4–12. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhao Z, Zhao M, Xiao G and Franceschi RT:
Gene transfer of the Runx2 transcription factor enhances osteogenic
activity of bone marrow stromal cells in vitro and in vivo. Mol
Ther. 12:247–253. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Taylor S, Hu R, Pacheco E, Locher K, Pyrah
I, Ominsky MS and Boyce RW: Differential time-dependent
transcriptional changes in the osteoblast lineage in cortical bone
associated with sclerostin antibody treatment in ovariectomized
rats. Bone Rep. 8:95–103. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhao W, Li X, Peng Y, Qin Y, Pan J, Li J,
Xu A, Ominsky MS, Cardozo C, Feng JQ, et al: Sclerostin antibody
reverses the severe sublesional bone loss in rats after chronic
spinal cord injury. Calcif Tissue Int. 103:443–454. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bhattacharyya S, Pal S and Chattopadhyay
N: Targeted inhibition of sclerostin for post-menopausal
osteoporosis therapy: A critical assessment of the mechanism of
action. Eur J Pharmacol. 826:39–47. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
McClung MR, Grauer A, Boonen S, Bolognese
MA, Brown JP, Diez-Perez A, Langdahl BL, Reginster JY, Zanchetta
JR, Wasserman SM, et al: Romosozumab in postmenopausal women with
low bone mineral density. N Engl J Med. 370:412–420. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lewiecki EM: Role of sclerostin in bone
and cartilage and its potential as a therapeutic target in bone
diseases. Ther Adv Musculoskelet Dis. 6:48–57. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mbalaviele G, Sheikh S, Stains JP, Salazar
VS, Cheng SL, Chen D and Civitelli R: Beta-catenin and BMP-2
synergize to promote osteoblast differentiation and new bone
formation. J Cell Biochem. 94:403–418. 2005. View Article : Google Scholar
|
|
25
|
Datta I, Bhadri N, Shahani P, Majumdar D,
Sowmithra S, Razdan R and Bhonde R: Functional recovery upon human
dental pulp stem cell transplantation in a diabetic neuropathy rat
model. Cytotherapy. 19:1208–1224. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Heidrich K, Thiede C, Schäfer-Eckart K,
Schmitz N, Aulitzky WE, Krämer A, Rösler W, Hänel M, Einsele H,
Baldus CD, et al: Allogeneic hematopoietic cell transplantation in
intermediate risk acute myeloid leukemia negative for FLT3-ITD,
NPM1- or biallelic CEBPA mutations. Ann Oncol. 28:2793–2798. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang Z, Wang D, Yang D, Zhen W, Zhang J
and Peng S: The effect of icariin on bone metabolism and its
potential clinical application. Osteoporos Int. 29:535–544. 2018.
View Article : Google Scholar
|
